Estrogen Receptors and Human Disease

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2006 Mar 3

PMID 16511588

Citations 497

Authors

Bonnie J Deroo

Kenneth S Korach

Affiliations

Soon will be listed here.

Abstract

Estrogens influence many physiological processes in mammals, including but not limited to reproduction, cardiovascular health, bone integrity, cognition, and behavior. Given this widespread role for estrogen in human physiology, it is not surprising that estrogen is also implicated in the development or progression of numerous diseases, which include but are not limited to various types of cancer (breast, ovarian, colorectal, prostate, endometrial), osteoporosis, neurodegenerative diseases, cardiovascular disease, insulin resistance, lupus erythematosus, endometriosis, and obesity. In many of these diseases, estrogen mediates its effects through the estrogen receptor (ER), which serves as the basis for many therapeutic interventions. This Review will describe diseases in which estrogen, through the ER, plays a role in the development or severity of disease.

Citing Articles

Monkey multi-organ cell atlas exposed to estrogen.

Fang W, Qu J, Zhao W, Cao X, Liu J, Han Q Life Med. 2025; 3(2):lnae012.

PMID: 39872660 PMC: 11749546. DOI: 10.1093/lifemedi/lnae012.

Transcriptomic Profiling Reveals 17β-Estradiol Treatment Represses Ubiquitin-Proteasomal Mediators in Skeletal Muscle of Ovariectomized Mice.

Kararigas G, Ebeling M, Le G, Lai S, Cui C, Cui Q J Cachexia Sarcopenia Muscle. 2025; 16(1):e13698.

PMID: 39865408 PMC: 11761681. DOI: 10.1002/jcsm.13698.

Regulation of enzymatic lipid peroxidation in osteoblasts protects against postmenopausal osteoporosis.

Zhang Q, Gong H, Jiang M, Jin F, Wang G, Yan C Nat Commun. 2025; 16(1):758.

PMID: 39824794 PMC: 11742680. DOI: 10.1038/s41467-025-55929-4.

Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer.

Palaniappan M Biomedicines. 2025; 12(12.

PMID: 39767607 PMC: 11673253. DOI: 10.3390/biomedicines12122700.

A comprehensive review on the effects of sex hormones on chemotherapy-induced cardiotoxicity: are they lucrative or unprofitable?.

Kheradkhah G, Sheibani M, Kianfar T, Toreyhi Z, Azizi Y Cardiooncology. 2024; 10(1):86.

PMID: 39627907 PMC: 11613924. DOI: 10.1186/s40959-024-00293-3.

References

Yoshidome K, Shibata M, Couldrey C, Korach K, Green J . Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Cancer Res. 2001; 60(24):6901-10. View

Ogawa S, Emi M, Shiraki M, Hosoi T, Ouchi Y, Inoue S . Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure. J Hum Genet. 2001; 45(6):327-30. DOI: 10.1007/s100380070002. View

Petanceska S, Nagy V, Frail D, Gandy S . Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp Gerontol. 2000; 35(9-10):1317-25. DOI: 10.1016/s0531-5565(00)00157-1. View

Risbridger G, Wang H, Young P, Kurita T, Wang Y, Lubahn D . Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol. 2001; 229(2):432-42. DOI: 10.1006/dbio.2000.9994. View

Braidman I, Hainey L, Batra G, Selby P, Saunders P, Hoyland J . Localization of estrogen receptor beta protein expression in adult human bone. J Bone Miner Res. 2001; 16(2):214-20. DOI: 10.1359/jbmr.2001.16.2.214. View

Campbell-Thompson M, Lynch I, Bhardwaj B . Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res. 2001; 61(2):632-40. View

Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H . ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol. 2001; 15(12):2064-77. DOI: 10.1210/mend.15.12.0741. View

Mueller S, Korach K . Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr Opin Pharmacol. 2002; 1(6):613-9. DOI: 10.1016/s1471-4892(01)00105-9. View

Sims N, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M . Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 2002; 30(1):18-25. DOI: 10.1016/s8756-3282(01)00643-3. View

10.

Mosca L . Rationale and overview of the Raloxifene Use for the Heart (RUTH) trial. Ann N Y Acad Sci. 2002; 949:181-5. DOI: 10.1111/j.1749-6632.2001.tb04018.x. View

11.

Zhu Y, Bian Z, Lu P, Karas R, Bao L, Cox D . Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 2002; 295(5554):505-8. DOI: 10.1126/science.1065250. View

12.

Taranta A, Brama M, Teti A, De Luca V, Scandurra R, Spera G . The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro. Bone. 2002; 30(2):368-76. DOI: 10.1016/s8756-3282(01)00685-8. View

13.

Herrington D, Howard T, Hawkins G, Reboussin D, Xu J, Zheng S . Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med. 2002; 346(13):967-74. DOI: 10.1056/NEJMoa012952. View

14.

Shang Y, Brown M . Molecular determinants for the tissue specificity of SERMs. Science. 2002; 295(5564):2465-8. DOI: 10.1126/science.1068537. View

15.

Lu H, Higashikata T, Inazu A, Nohara A, Yu W, Shimizu M . Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2002; 22(5):817-23. DOI: 10.1161/01.atv.0000014424.18209.21. View

16.

Hewitt S, Bocchinfuso W, Zhai J, Harrell C, Koonce L, Clark J . Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu. Cancer Res. 2002; 62(10):2798-805. View

17.

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

18.

Burns K, Agno J, Chen L, Haupt B, Ogbonna S, Korach K . Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis. Mol Endocrinol. 2003; 17(10):2039-52. DOI: 10.1210/me.2003-0039. View

19.

Marin R, Guerra B, Hernandez-Jimenez J, Kang X, Fraser J, Lopez F . Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor. Neuroscience. 2003; 121(4):917-26. DOI: 10.1016/s0306-4522(03)00464-0. View

20.

Couse J, Korach K . Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev. 1999; 20(3):358-417. DOI: 10.1210/edrv.20.3.0370. View